journal article·2020-09-09

A Tale of Drug-Carrier Optimization: Controlling Stimuli Sensitivity via Nanoparticle Hydrophobicity through Drug Loading

Yen-Nan Lin, Sarosh Khan, Yue Song, Mei Dong, Yidan Shen, David K. Tran, Ching Pang, Fuwu Zhang, Karen L. Wooley

Nano Letters· Volume 20· Issue 9
Publisher page

Abstract

Interactions between drug molecules, nanocarrier components, and surrounding media influence the properties and therapeutic efficacies of nanomedicines. In this study, we investigate the role that reversible covalent loading of a hydrophobic drug exerts on intra-nanoparticle physical properties and explore the utility of this payload control strategy for tuning the access of active agents and, thereby, the stimuli sensitivity of smart nanomaterials. Glutathione sensitivity was controlled via altering the degree of hydrophobic payload loading of disulfide-linked camptothecin-conjugated sugar-based nanomaterials. Increases in degrees of camptothecin conjugation (fCPT) decreased aqueous accessibility and reduced glutathione-triggered release. Although the lowest fCPT gave the fastest camptothecin release, it resulted in the lowest camptothecin concentration. Remarkably, the highest fCPT resulted in a 5.5-fold improved selectivity against cancer vs noncancerous cells. This work represents an advancement in drug carrier design by demonstrating the importance of controlling the amount of drug loading on the overall payload and its availability.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Chemistry, Chemical Engineering, and Materials Science & Engineering, Laboratory for Synthetic−Biologic Interactions, Texas A&M University, College Station, Texas 77842, United States

College of Medicine, Texas A&M University, Bryan, Texas 77807, United States

Funding

Division of Chemistry · Welch Foundation · Directorate for Mathematical and Physical Sciences · Division of Materials Research · Laboratory for Synthetic-Biologic Interactions, Texas A and M University

References (78)

Show source-provided references
1. 10.1021/mp400114n10.1021/mp400114n ↗
2. 10.1016/j.biomaterials.2018.05.03410.1016/j.biomaterials.2018.05.034 ↗
3. 10.1039/C9NA00282K10.1039/C9NA00282K ↗
4. 10.1021/acs.nanolett.8b0401710.1021/acs.nanolett.8b04017 ↗
5. 10.1021/acs.nanolett.9b0166010.1021/acs.nanolett.9b01660 ↗
6. 10.1021/acsmaterialslett.0c0004410.1021/acsmaterialslett.0c00044 ↗
7. 10.1124/mol.116.10808410.1124/mol.116.108084 ↗
8. 10.1021/acs.nanolett.9b0037410.1021/acs.nanolett.9b00374 ↗
9. 10.1021/acs.nanolett.9b0509410.1021/acs.nanolett.9b05094 ↗
10. 10.1021/bc060201d10.1021/bc060201d ↗
11. 10.1021/jacs.7b1146210.1021/jacs.7b11462 ↗
12. 10.1016/j.nantod.2010.10.00610.1016/j.nantod.2010.10.006 ↗
13. 10.1021/mp300589710.1021/mp3005897 ↗
14. 10.1021/jacs.7b1277610.1021/jacs.7b12776 ↗
15. 10.1016/j.molliq.2018.08.03210.1016/j.molliq.2018.08.032 ↗
16. 10.3390/ma1307151010.3390/ma13071510 ↗
17. 10.1039/c2cs15327k10.1039/c2cs15327k ↗
18. 10.1073/pnas.060099710310.1073/pnas.0600997103 ↗
19. 10.1038/nnano.2007.7010.1038/nnano.2007.70 ↗
20. 10.1038/nrd259110.1038/nrd2591 ↗
21. 10.1002/anie.20140303610.1002/anie.201403036 ↗
22. 10.1021/acs.nanolett.8b0107110.1021/acs.nanolett.8b01071 ↗
23. 10.1016/j.progpolymsci.2019.10114710.1016/j.progpolymsci.2019.101147 ↗
24. Russo A. · Cancer Res. · 1986 · 46 · 2845
25. 10.1146/annurev.micro.51.1.17910.1146/annurev.micro.51.1.179 ↗
26. 10.1016/S0891-5849(01)00480-410.1016/S0891-5849(01)00480-4 ↗
27. Kuppusamy P. · Cancer Res. · 2002 · 62 · 307
28. 10.1016/S0169-409X(02)00179-510.1016/S0169-409X(02)00179-5 ↗
29. 10.1021/bm200275j10.1021/bm200275j ↗
30. 10.1016/j.progpolymsci.2008.07.00510.1016/j.progpolymsci.2008.07.005 ↗
31. 10.1021/acs.chemmater.7b0020710.1021/acs.chemmater.7b00207 ↗
32. Thorpe P. E. · Cancer Res. · 1987 · 47 · 5924
33. 10.1021/bc970025w10.1021/bc970025w ↗
34. 10.1021/bc100480a10.1021/bc100480a ↗
35. 10.1002/chem.20140490910.1002/chem.201404909 ↗
36. 10.1039/C6RA01778A10.1039/C6RA01778A ↗
37. 10.1021/bm200516410.1021/bm2005164 ↗
38. 10.1021/acsnano.7b0300310.1021/acsnano.7b03003 ↗
39. 10.1021/acsami.9b0810010.1021/acsami.9b08100 ↗
40. 10.1016/j.progpolymsci.2016.09.00510.1016/j.progpolymsci.2016.09.005 ↗
41. 10.1021/acs.nanolett.9b0276910.1021/acs.nanolett.9b02769 ↗
42. 10.1016/j.jconrel.2011.01.03010.1016/j.jconrel.2011.01.030 ↗
43. 10.1002/chem.20110102410.1002/chem.201101024 ↗
44. 10.1021/bm400501c10.1021/bm400501c ↗
45. 10.1021/acsmacrolett.9b0009410.1021/acsmacrolett.9b00094 ↗
46. 10.1002/ijch.20190016010.1002/ijch.201900160 ↗
47. 10.1039/C5RA24903A10.1039/C5RA24903A ↗
48. 10.1039/C3PY00852E10.1039/C3PY00852E ↗
49. 10.1021/ma061420x10.1021/ma061420x ↗
50. 10.1021/ja106993210.1021/ja1069932 ↗
51. 10.1021/ja102316a10.1021/ja102316a ↗
52. 10.1021/mz400515s10.1021/mz400515s ↗
53. 10.1021/ar400033910.1021/ar4000339 ↗
54. 10.1016/j.nantod.2015.11.00410.1016/j.nantod.2015.11.004 ↗
55. Nuttall K. L. · Ann. Clin. Lab. Sci. · 2006 · 36 · 409
56. 10.1016/j.toxlet.2013.11.01610.1016/j.toxlet.2013.11.016 ↗
57. 10.1001/jamaneurol.2018.166910.1001/jamaneurol.2018.1669 ↗
58. 10.1021/bc900339x10.1021/bc900339x ↗
59. 10.1002/asia.20130103010.1002/asia.201301030 ↗
60. 10.1039/C5TB00623F10.1039/C5TB00623F ↗
61. 10.1021/acs.nanolett.7b0353110.1021/acs.nanolett.7b03531 ↗
62. 10.1039/C6PY01978A10.1039/C6PY01978A ↗
63. 10.1039/C8QM00353J10.1039/C8QM00353J ↗
64. 10.1002/pola.2922910.1002/pola.29229 ↗
65. 10.1039/D0PY00029A10.1039/D0PY00029A ↗
66. 10.1139/v63-43610.1139/v63-436 ↗
67. 10.1080/0026897640010023110.1080/00268976400100231 ↗
68. 10.1002/mrc.126023080710.1002/mrc.1260230807 ↗
69. 10.1002/anie.20180198410.1002/anie.201801984 ↗
70. 10.1016/S0020-7292(06)60033-710.1016/S0020-7292(06)60033-7 ↗
71. 10.1021/mp900243b10.1021/mp900243b ↗
72. Gershenson D. M. · Oncology (Williston Park) · 2002 · 16 · 29
73. 10.1200/JCO.2003.02.09110.1200/JCO.2003.02.091 ↗
74. 10.1016/j.ygyno.2016.11.04310.1016/j.ygyno.2016.11.043 ↗
75. 10.2174/15733940677793471710.2174/157339406777934717 ↗
76. Shao L. · Transl. Cancer Res. · 2013 · 2 · 397
77. 10.1186/s13058-015-0669-x10.1186/s13058-015-0669-x ↗
78. 10.1038/nature0204010.1038/nature02040 ↗